In another 2006 clinical trial,(10)72 test subjects with pressure ulcers were presented with TB-500. The main aim of this randomized, double blind study was to establish the potential of thymosin beta 4 (analogous to TB-500) in ulcer presence
Once the medication is in circulation, it is processed and removed at a gradual pace by the bodys natural systems
People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications compared with those who receive other antidiabetic medications, two studies show
Florenzano P, Ferreira C, Nesterova G, Roberts MS, Tella SH, de Castro LF, Brown SM, Whitaker A, Pereira RC, Bulas D, Gafni RI, Salusky IB, Gahl WA, Collins MT (2018) Skeletal consequences of nephropathic cystinosis